Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | COVID-19 Vaccination | Research

Exploration of attitudes regarding uptake of COVID-19 vaccines among vaccine hesitant adults in the UK: a qualitative analysis

Authors: Sarah Denford, Fiona Mowbray, Lauren Towler, Helena Wehling, Gemma Lasseter, Richard Amlôt, Isabel Oliver, Lucy Yardley, Matthew Hickman

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

The aim of this work was to explore barriers and facilitators to uptake of COVID-19 vaccines and to explore views and reactions to efforts to improve vaccine uptake among vaccine hesitant individuals.

Methods

Semi-structured interviews were conducted with people between the age of 18–29 years who had not had a COVID-19 vaccine, and those between 30 and 49 years who had not had a second dose of a COVID-19 vaccine.

Results

A total of 70 participants took part in the study, 35 participants had received one dose, and 35 had not been vaccinated. Participants described a willingness to be vaccinated to keep themselves and those around them safe and to avoid restrictions. Barriers to uptake included: (1) perceived lack of need for COVID-19 vaccinations, (2) concerns about the efficacy of vaccinations, (3) concerns about safety, and (4) access issues. Uptake appeared to be influenced by age and health status, trust in government, and knowledge and understanding of science. Introduction of vaccine passes may provide a motive for having a vaccine but may be viewed as coercive.

Conclusion

Participants were hesitant, rather than opposed, and had questions about their need for, and the safety and efficacy of the vaccine. Young people did not consider themselves to be at risk of becoming ill from COVID-19, did not think the vaccination was effective in preventing transmission, and did not think sufficient research had been conducted regarding possible long-term side-effects. Concerns were exacerbated by a lack of trust in government, and misunderstanding of science. To promote uptake, public health campaigns should focus on the provision of information from trusted sources that explains the benefits of vaccination and addresses safety concerns more effectively. To overcome inertia in people with low levels of motivation to be vaccinated, appointments must be easily accessible.
Appendix
Available only for authorised users
Literature
3.
go back to reference Tregoning J, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines, and variants versus efficacy, effectiveness, and escape. Nat Rev Immunol. 2021;21:626–623.CrossRef Tregoning J, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines, and variants versus efficacy, effectiveness, and escape. Nat Rev Immunol. 2021;21:626–623.CrossRef
9.
go back to reference Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptabilty and its predictors. Prev Med. 2021;150: 106694.CrossRef Wang Q, Yang L, Jin H, Lin L. Vaccination against COVID-19: a systematic review and meta-analysis of acceptabilty and its predictors. Prev Med. 2021;150: 106694.CrossRef
10.
go back to reference MacDonald N, The Sage Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope, and determinants. Vaccine. 2015;33:4161–4.CrossRef MacDonald N, The Sage Working Group on Vaccine Hesitancy. Vaccine hesitancy: definition, scope, and determinants. Vaccine. 2015;33:4161–4.CrossRef
11.
go back to reference Razai M, Oakeshott P, Esmail A, Wiysonge CS, Kasisomayajula V, Mills MC. COVID-19 and vaccine hesitancy: the five cs to takle behavioural and sociodemographic factors. J R Soc Med. 2021;114(6):295–8.CrossRef Razai M, Oakeshott P, Esmail A, Wiysonge CS, Kasisomayajula V, Mills MC. COVID-19 and vaccine hesitancy: the five cs to takle behavioural and sociodemographic factors. J R Soc Med. 2021;114(6):295–8.CrossRef
13.
go back to reference Robertson E, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal survey. Brain Behav Immun. 2021;94:41–50.CrossRef Robertson E, et al. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal survey. Brain Behav Immun. 2021;94:41–50.CrossRef
14.
go back to reference The OpenSAFELY Collaborative. Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY. MedRxiv [Preprint]. 2021. Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY | medRxiv. The OpenSAFELY Collaborative. Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY. MedRxiv [Preprint]. 2021. Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY | medRxiv.
17.
go back to reference Anderson E, Brigden A, Davies A, Shepherd E, Ingram J. Maternal vaccines during the Covid-19 pandemic: a qualitative interview study with UK pregnant women. Midwifery. 2021;100: 103062.CrossRef Anderson E, Brigden A, Davies A, Shepherd E, Ingram J. Maternal vaccines during the Covid-19 pandemic: a qualitative interview study with UK pregnant women. Midwifery. 2021;100: 103062.CrossRef
20.
go back to reference Braun V, Clark V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589–97.CrossRef Braun V, Clark V. Reflecting on reflexive thematic analysis. Qual Res Sport Exerc Health. 2019;11(4):589–97.CrossRef
21.
go back to reference Braun V, Clark V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef Braun V, Clark V. Using thematic analysis in psychology. Qual Res Psychol. 2006;3(2):77–101.CrossRef
22.
go back to reference Timmermans S, Tavory I. Theory construction in qualitative research: from grounded theory to abductive analysis. Sociol Theory. 2012;30(3):167–86.CrossRef Timmermans S, Tavory I. Theory construction in qualitative research: from grounded theory to abductive analysis. Sociol Theory. 2012;30(3):167–86.CrossRef
23.
go back to reference Mitchell K, Clark A. Enhance your qualitative analysis with writing: Four principles of writing as inquiry. Int J Qual Methods. 2021;20:1–5.CrossRef Mitchell K, Clark A. Enhance your qualitative analysis with writing: Four principles of writing as inquiry. Int J Qual Methods. 2021;20:1–5.CrossRef
26.
go back to reference Vergara RJD, Sarmiento PJD, Lagman JDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health. 2021;43(2): e291.CrossRef Vergara RJD, Sarmiento PJD, Lagman JDN. Building public trust: a response to COVID-19 vaccine hesitancy predicament. J Public Health. 2021;43(2): e291.CrossRef
27.
go back to reference Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HL. Strategies for addressing vaccine hesitancy—a systematic review. Vaccine. 2015;33(34):4180–90.CrossRef Jarrett C, Wilson R, O’Leary M, Eckersberger E, Larson HL. Strategies for addressing vaccine hesitancy—a systematic review. Vaccine. 2015;33(34):4180–90.CrossRef
30.
go back to reference Opdenakker R. Advantages and disadvantages of four interview texhniques in qualitative research. Forum Qual Soz/Forum Qual Soc Res. 2006;7(4):175. Opdenakker R. Advantages and disadvantages of four interview texhniques in qualitative research. Forum Qual Soz/Forum Qual Soc Res. 2006;7(4):175.
Metadata
Title
Exploration of attitudes regarding uptake of COVID-19 vaccines among vaccine hesitant adults in the UK: a qualitative analysis
Authors
Sarah Denford
Fiona Mowbray
Lauren Towler
Helena Wehling
Gemma Lasseter
Richard Amlôt
Isabel Oliver
Lucy Yardley
Matthew Hickman
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07380-9

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue